Efficacy and safety of canagliflozin in kidney transplant patients

Conclusion: Canagliflozin provided reductions in body weight, BP, HbA1c, and the requirement of other hypoglycemic agents without any hypoglycemic episodes and without significant AEs.

Source: Indian Journal of Nephrology - July 15, 2019 Category: Urology & Nephrology Authors: Mita Shah Zaheer Virani Prashant Rajput Bharat Shah Source Type: research